Gregory B. Lesinski
0000-0002-8787-7678
Publication & Citation Trends
Most Cited Works
Publications
463 total
Abstract PS2-08-14: Chemokine signatures improve PD-L1-based prediction of pembrolizumab response in triple-negative breast cancer
Cited by 0
Semantic Scholar
Abstract LB-C007: Enhancing immune interactions in tumor with pepinemab SEMA4D blocking antibody
Cited by 0
Semantic Scholar
Loss of miR-29a/b1 cluster reprograms the tumor microenvironment and contributes to immunosuppression in lung cancer.
Cited by 0
Semantic Scholar
Neoantigens drive adoptively transferred CD8 T cells to long-lived effectors mediated by lymph node trafficking
Cited by 0
Semantic Scholar
T-cell Priming by High-Avidity Neoantigens in Lymph Nodes Augments Adoptive Immunotherapy
Cited by 0
Semantic Scholar
Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunity
Cited by 8
Semantic Scholar
Adoptively transferred naïve CD8 T cells develop enhanced effector function and improved persistence in neoantigen tumors 4282
Cited by 0
Semantic Scholar
Endogenous ICOS signaling supports Th17 therapy efficacy
Cited by 0
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(96)
Pancreatic and Hepatic Oncology Research
(95)
CAR-T cell therapy research
(58)
Cytokine Signaling Pathways and Interactions
(45)
Immunotherapy and Immune Responses
(44)
Frequent Co-Authors
Affiliations
University of Toledo Medical Center
Emory Healthcare
Johns Hopkins University
Emory University
Emory and Henry College